Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UAU201408681UpriorityCriticalpatent/UA96476U/en
Publication of UA96476UpublicationCriticalpatent/UA96476U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Застосування 7-(3-гідроксифеніл)-6-карбетокси-5-метил-4,7-дигідро[1,2,4]триазоло-[1,5-а]піримідину для корекції порушень структури кісткової тканини при гіпотиреоїдних станах. Вводять у дозі 10 мг/кг перорально у 2 % крохмальному розчині протягом 10 діб.The use of 7- (3-hydroxyphenyl) -6-carbethoxy-5-methyl-4,7-dihydro [1,2,4] triazolo- [1,5-a] pyrimidine for the correction of bone structure disorders in hypothyroid states. It is administered at a dose of 10 mg / kg orally in 2% starch solution for 10 days.
UAU201408681U2014-07-312014-07-31
APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION
UA96476U
(en)
CRYSTALLINE FORM (S) -7- (1-ACRYLOYLPIPERIDIN-4-IL) -2- (4-PHENOXYPHENYL) -4,5,6,7-TETHRHYDROPYRAZOLO [1,5-a] PYRIMIDIN-3-CARBOXAMIDE, ITS PRODUCTION AND APPLICATIONS
Compounds derived from pyrazolo (4.3-d) pyrimidines, kinase inhibitors; pharmaceutical composition; and use for the treatment of diseases and disorders of the respiratory system
Crystalline forms of (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido [1',2':4,5] pyrazino [2,1-b] [1,3] oxazepine-10-carboxamide
[1,2,4]triazolo[1,5-A]pyrimidine derivatives As proteasome inhibitors of Protozoa for the treatment of diseases caused by parasites such as leishmaniasis.